Replimune Group, Inc. - 10-Q filing on 2020-02-13

Fair value of financial assets and liabilities (Tables)

9 Months Ended

Dec. 31, 2019

Fair value of financial assets and liabilities

Schedule of company's financial assets and liabilities measured at fair value on a recurring basis


		Fair Value Measurements as of
		December 31, 2019 Using:
		Level 1			Level 2			Level 3			Total
Assets
Money market funds		$	—		$	35,853		$	—		$	35,853
Commercial paper			—			42,172			—			42,172
US Government Agency bonds			—			23,158			—			23,158
US Treasury bonds			—			28,105			—			28,105
Corporate debt securities			—			34,564			—			34,564
		$	—		$	163,852		$	—		$	163,852


		Fair Value Measurements as of
		March 31, 2019 Using:
		Level 1			Level 2			Level 3			Total
Assets
Money market funds		$	—		$	2,676		$	—		$	2,676
Commercial paper			—			46,687			—			46,687
US Government Agency bonds			—			20,884			—			20,884
US Treasury bonds			—			41,057			—			41,057
Corporate debt securities			—			8,467			—			8,467
		$	—		$	119,771		$	—		$	119,771

Schedule of unobservable inputs of the warrant liability upon the conversion date


		Nine Months
		Ended
		December 31,
		2018
Risk-free interest rate			2.81	%
Expected dividend yield			0	%
Expected term (in years)			7.2
Expected volatility			64.4	%
Fair value of series seed preferred stock		$	15.00

Schedule of roll forward of the warrant liability


		Warrant
		Liability
Balance at March 31, 2018		$	1,642
Change in fair value			5,452
Conversion of convertible preferred stock warrant into common stock warrant			(7,094)
Balance at December 31, 2018		$	—